
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/OVDZMWWEUVEMDOWX6O2KTMS2TQ.jpg)
In the fall of 1993 Dupont Merck decided to achieve some focus by establishing a subsidiary to serve as its generic division. The resulting company proved to be a cipher to customers, who were unsure what to make of its mix of injectable drugs, off-patent brands, and the other products it distributed for other companies. This collaboration led a year later to the two parties creating an independent joint venture, The DuPont Merck Pharmaceuticals Company, to which DuPont contributed its pharmaceutical holdings. In 1989 DuPont and giant pharmaceutical Merck and Company entered into a research and marketing arrangement. Endo began developing other drugs, although in 1983 DuPont decided to stop using the Endo name for its pharmaceutical division. By the early 1980s Endo was generating about $100 million in annual sales, hardly enough to prompt DuPont, which had more than $22 billion in annual sales at the time, to take much notice. Unfortunately Endo's marketing efforts failed to achieve the kind of growth DuPont was looking for in Symmetrel, due in large measure to the bureaucracy of the parent company. The primary reason DuPont acquired Endo was because of its marketing capabilities. Just three years earlier DuPont had become involved in the pharmaceutical industry after one of its researchers developed an antiviral drug called Symmetrel, effective in treating flus. du Pont de Nemours & Company, better known as DuPont. The family-run business eventually relocated to Long Island, and then in 1969 was acquired by E.I. The heritage of the Endo name dates to 1920 when five brothers of the Ushkow family established Endo Laboratories, a small pharmaceutical company, in Manhattan, New York. The company is 60 percent owned by investment firm Kelso & Company. Endo markets its products to primary care physicians and specialists, as well as to other healthcare professionals and retail pharmacies. On the generic side, Endo markets Morphine Sulfate ER (extended release) tablets to treat moderate to severe pain, and Endocet, a generic equivalent to Percocet.

The company also offers branded pharmaceuticals to relieve serious coughing and congestion: Hycodan, Hycomine, and Hycotuss. Endo's branded products include Percocet, using oxycodone and acetaminophen to treat moderate to moderately severe pain Percodan, using oxycodone and aspirin to treat less severe pain the Lidoderm patch, used to relieve pain caused by shingles and Frova, using frovatriptan to treat migraines. Endo develops and sells both branded and generic prescription pharmaceuticals, with its manufacturing contracted out to third parties. is a publicly traded company based in the Philadelphia, Pennsylvania area, dedicated to the niche of pain management.
#ENDO PHARMACEUTICALS PENNSYLVANIA FULL#
Compare Standard and Premium Digital here.Īny changes made can be done at any time and will become effective at the end of the trial period, allowing you to retain full access for 4 weeks, even if you downgrade or cancel.NAIC: 325412 Pharmaceutical Preparation ManufacturingĮndo Pharmaceuticals Holdings Inc. You may also opt to downgrade to Standard Digital, a robust journalistic offering that fulfils many user’s needs. If you’d like to retain your premium access and save 20%, you can opt to pay annually at the end of the trial. If you do nothing, you will be auto-enrolled in our premium digital monthly subscription plan and retain complete access for $69 per month.įor cost savings, you can change your plan at any time online in the “Settings & Account” section. For a full comparison of Standard and Premium Digital, click here.Ĭhange the plan you will roll onto at any time during your trial by visiting the “Settings & Account” section. Premium Digital includes access to our premier business column, Lex, as well as 15 curated newsletters covering key business themes with original, in-depth reporting. Standard Digital includes access to a wealth of global news, analysis and expert opinion. During your trial you will have complete digital access to FT.com with everything in both of our Standard Digital and Premium Digital packages.
